Abstract:Objective To assess the mid-long term stability of primary used VerSys Advocate cemented femoral stem in osteoporotic patients and analyze the factors affected the stability of implants. Method To finish the total hip arthplasty for 182 (222 hips) osteoporotic patients from May 2004 to May 2010 who need to be accomplished and used the VerSys Advocate cemented femoral stem. Followed up regularly for their post-operative complications, radiologic information. Harris score and determination of bone density value were used for statistical analysis. Analyzed the survival rate for implants. Results A total of 118 patients (144 hips) were completely followed up for 2 to 10 years,6.1 on average. The mean preoperative Harris hip score of (33.5±14.8) points significantly improved to (84.3 ± 15.2) points at the final follow-up. Femoral calcar cleavage fracture and intertrochanteric fracture occurred in 1 hip each other during the surgery. There was deep venous thrombosis (DVT) in 4 patients (5 hips), late infection in 2 hips, aseptic loosening in 3 hips.7 hips were accepted the revision surgery. The survival rate of the implants was 96.5%. Conclusions The study indicated that the VerSys Advocate cemented femoral stem has a encouraging mid-long term clinical results for osteoporotic patients, for whom the incidence of aseptic loosening was low and the mid-long term survival rate was sufficient.